GLOW Blend 70MG

The GLOW blend 70MG from Maple Research Labs is a premium multi-peptide research formulation. This GLOW blend 70MG combines GHK-Cu, BPC-157, and Epithalon in a single 70mg vial for comprehensive research protocols. Researchers across Canada choose our GLOW blend 70MG for its verified 99%+ purity and third-party testing.

GLOW Blend 70MG Research Compound Overview

GLOW blend 70MG from Maple Research Labs is a multi-peptide research formulation combining GHK-Cu, BPC-157, and Epithalon in a single 70mg vial with verified purity and third-party COA testing.

The GLOW Blend is a multi-peptide research formulation combining BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) into a single 70mg lyophilized vial. Developed for in-vitro and preclinical research applications, the GLOW Blend offers investigators a streamlined approach to studying the interplay between tissue remodeling, extracellular matrix regulation, and angiogenic signaling pathways.

Why Choose GLOW blend 70MG from Maple Research

Researchers across Canada choose Maple Research Labs for verified purity and same-day shipping on all orders.

GLOW Blend Product Specifications

• CAS Numbers: BPC-157: 137525-51-0 / GHK-Cu: 49557-75-7 / TB-500: 77591-33-4
• Composition: BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg)
• Purity: >99%+ (HPLC verified, each component)
• Form: Lyophilized powder
• Quantity: 70mg per vial
• Testing: Third-party COA verified by independent laboratory

GLOW Blend Research Summary

The GLOW Blend combines three peptides that have been individually investigated for their roles in tissue biology. BPC-157, a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein, has been studied in animal models for its effects on vascular endothelial growth factor (VEGF) expression and nitric oxide synthase (NOS) system modulation. Published research has examined BPC-157 in the context of wound healing, tendon repair, and gastrointestinal tissue integrity in rodent models (Sikiric et al., 2010).

GHK-Cu is a naturally occurring copper-binding tripeptide investigated in cell culture models for its influence on collagen synthesis, glycosaminoglycan production, and matrix metalloproteinase (MMP) activity. Research has demonstrated that GHK-Cu modulates gene expression related to tissue remodeling in fibroblast culture systems (Pickart et al., 2014).

TB-500 (Thymosin Beta-4 fragment) has been examined in preclinical research for its role in actin sequestration and cellular migration signaling. Studies in animal models have explored its potential involvement in tissue repair and inflammatory response modulation.

Why Researchers Choose the GLOW Blend

Preclinical research has explored the individual components of the GLOW Blend across distinct but potentially complementary biological pathways. In-vitro studies with BPC-157 have examined its effects on fibroblast migration, endothelial tube formation, and inflammatory cytokine modulation. GHK-Cu has been investigated in keratinocyte and fibroblast culture models for its effects on tissue remodeling gene expression, including elastin, decorin, and various collagen subtypes. TB-500 research in animal models has focused on its interaction with the actin cytoskeleton and its influence on cell motility and differentiation markers.

The GLOW Blend provides researchers with a tool for studying the interplay between angiogenic signaling (BPC-157), extracellular matrix regulation (GHK-Cu), and cytoskeletal dynamics (TB-500) within a single experimental framework. Each component targets distinct molecular pathways, allowing researchers to investigate potential synergistic or additive effects in tissue biology models. This multi-target approach makes the GLOW Blend particularly relevant for laboratories studying wound repair mechanisms, connective tissue biology, and regenerative medicine pathways.

GLOW Blend Purity and Quality Assurance

Every batch of the GLOW Blend manufactured by Maple Research Labs undergoes rigorous quality control procedures. Each peptide component is synthesized using solid-phase peptide synthesis (SPPS) and purified via reverse-phase high-performance liquid chromatography (RP-HPLC) to achieve purity levels exceeding 99%. Independent third-party laboratory testing confirms the identity, purity, and potency of each component before the GLOW Blend is released for distribution.

Researchers can access batch-specific Certificates of Analysis (COA) for every GLOW Blend order. These documents include HPLC chromatograms, mass spectrometry data, and amino acid analysis results, providing the transparency required for reproducible experimental outcomes. Maple Research Labs maintains this commitment to analytical verification as a core element of its quality assurance program for all research peptide products.

Storage and Handling

Store lyophilized peptide at -20°C. Reconstituted solution should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles. Each GLOW Blend vial is shipped with batch-specific documentation to ensure traceability and research reproducibility.

Shipping

Ships same-day from our Canadian facility. All orders include temperature-controlled packaging. The GLOW Blend ships to all provinces across Canada with tracked delivery.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

When ordering GLOW blend 70MG from Maple Research Labs, researchers receive a multi-peptide formulation with verified purity. Each GLOW blend 70MG vial undergoes third-party analytical testing before shipping.